Kao; Charlly

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kao; Charlly.The latest application filed is for "methods of diagnosing and treating tourette syndrome".

Company Profile

4.8.18

Kao; Charlly - Philadelphia PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods Of Diagnosing And Treating Tourette Syndrome App 20220296582 - Hakonarson; Hakon ; et al.	2022-09-22
Methods Of Diagnosing And Treating Conduct Disorder App 20220117953 - Hakonarson; Hakon ; et al.	2022-04-21
Methods Of Diagnosing And Treating Anxiety Disorder App 20220117954 - Hakonarson; Hakon ; et al.	2022-04-21
Compositions And Methods For The Diagnosis And Treatment Of Lymphatic System Disorders App 20220112558 - Hakonarson; Hakon ; et al.	2022-04-14
Methods of diagnosing and treating Tourette syndrome Grant 11,298,347 - Hakonarson , et al. April 12, 2	2022-04-12
Methods of diagnosing and treating autism Grant 11,219,617 - Hakonarson , et al. January 11, 2	2022-01-11
Methods of diagnosing and treating conduct disorder Grant 11,179,378 - Hakonarson , et al. November 23, 2	2021-11-23
Methods of diagnosing and treating anxiety disorder Grant 11,173,153 - Hakonarson , et al. November 16, 2	2021-11-16
Nonselective Metabotropic Glutamate Receptor Activators For Treatment Of Anorexia Nervosa And Binge Eating Disorder App 20210267958 - Hakonarson; Hakon ; et al.	2021-09-02
Novel Topical Formulation For Intradermal Application And Uses Thereof App 20210251973 - HAKONARSON; Hakon ; et al.	2021-08-19
Nonselective Metabotropic Glutamate Receptor Activators For Treatment Of Attention Deficit Disorder And 22q Syndrome App 20210205288 - Hakonarson; Hakon ; et al.	2021-07-08
Nonselective metabotropic glutamate receptor activators for treatment of anorexia nervosa and binge eating disorder Grant 10,918,632 - Hakonarson , et al. February 16, 2	2021-02-16
Nonselective metabotropic glutamate receptor activators for treatment of attention deficit disorder and 22Q syndrome Grant 10,869,861 - Hakonarson , et al. December 22, 2	2020-12-22
Methods Of Diagnosing And Treating Tourette Syndrome App 20200306237 - Hakonarson; Hakon ; et al.	2020-10-01
Nonselective Metabotropic Glutamate Receptor Activators For Treatment Of Anorexia Nervosa And Binge Eating Disorder App 20190298706 - Hakonarson; Hakon ; et al.	2019-10-03
Methods of treating autoimmune conditions in patients with genetic variations in DcR3 or in a DcR3 network gene Grant 10,407,725 - Hakonarson , et al. Sept	2019-09-10
Nonselective Metabotropic Glutamate Receptor Activators For Treatment Of Attention Deficit Disorder And 22q Syndrome App 20180110767 - Hakonarson; Hakon ; et al.	2018-04-26
Nonselective metabotropic glutamate receptor activators for treatment of attention deficit disorder and 22Q syndrome Grant 9,884,057 - Hakonarson , et al. February 6, 2	2018-02-06
Nonselective Metabotropic Glutamate Receptor Activators For Treatment Of Attention Deficit Disorder And 22q Syndrome App 20170105985 - Hakonarson; Hakon ; et al.	2017-04-20
Methods Of Diagnosing And Treating Anxiety Disorder App 20170087141 - Hakonarson; Hakon ; et al.	2017-03-30
Methods Of Diagnosing And Treating Conduct Disorder App 20170087140 - Hakonarson; Hakon ; et al.	2017-03-30
Methods Of Diagnosing And Treating Tourette Syndrome App 20170087139 - Hakonarson; Hakon ; et al.	2017-03-30
Methods of Diagnosing and Treating Autism App 20170083664 - Hakonarson; Hakon ; et al.	2017-03-23
Methods of Treating Autoimmune Conditions in Patients with Genetic Variations in DCR3 or in a DCR3 Network Gene App 20170051352 - Hakonarson; Hakon ; et al.	2017-02-23
Genetic Alterations Associated with Autism and the Autistic Phenotype and Methods of Use Thereof for the Diagnosis and Treatment of Autism App 20160244831 - Hakonarson; Hakon ; et al.	2016-08-25
Genetic Alterations Associated with Autism and the Autistic Phenotype and Methods of Use Thereof for the Diagnosis and Treatment of Autism App 20140303243 - Hakonarson; Hakon ; et al.	2014-10-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.